Effects of nutrition therapy on growth, inflammation and metabolism in immature infants: a study protocol of a double-blind randomized controlled trial (ImNuT).


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
07 01 2021
Historique:
received: 14 08 2020
accepted: 10 11 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 28 5 2021
Statut: epublish

Résumé

Current nutritional management of infants born very preterm results in significant deficiency of the essential fatty acids (FAs) arachidonic acid (ARA) and docosahexaenoic acid (DHA). The impact of this deficit on brain maturation and inflammation mediated neonatal morbidities are unknown. The aim of this study is to determine whether early supply of ARA and DHA improves brain maturation and neonatal outcomes in infants born before 29 weeks of gestation. Infants born at Oslo University Hospital are eligible to participate in this double-blind randomized controlled trial. Study participants are randomized to receive an enteral FA supplement of either 0.4 ml/kg MCT-oil™ (medium chain triglycerides) or 0.4 ml/kg Formulaid™ (100 mg/kg of ARA and 50 mg/kg of DHA). The FA supplement is given from the second day of life to 36 weeks' postmenstrual age (PMA). The primary outcome is brain maturation assessed by Magnetic Resonance Imaging (MRI) at term equivalent age. Secondary outcomes include quality of growth, incidence of neonatal morbidities, cardiovascular health and neuro-development. Target sample size is 120 infants (60 per group), this will provide 80% power to detect a 0.04 difference in mean diffusivity (MD, mm Supplementation of ARA and DHA has the potential to improve brain maturation and reduce inflammation related diseases. This study is expected to provide valuable information for future nutritional guidelines for preterm infants. Clinicaltrials.gov ID: NCT03555019 . Registered 4 October 2018- Retrospectively registered.

Sections du résumé

BACKGROUND
Current nutritional management of infants born very preterm results in significant deficiency of the essential fatty acids (FAs) arachidonic acid (ARA) and docosahexaenoic acid (DHA). The impact of this deficit on brain maturation and inflammation mediated neonatal morbidities are unknown. The aim of this study is to determine whether early supply of ARA and DHA improves brain maturation and neonatal outcomes in infants born before 29 weeks of gestation.
METHODS
Infants born at Oslo University Hospital are eligible to participate in this double-blind randomized controlled trial. Study participants are randomized to receive an enteral FA supplement of either 0.4 ml/kg MCT-oil™ (medium chain triglycerides) or 0.4 ml/kg Formulaid™ (100 mg/kg of ARA and 50 mg/kg of DHA). The FA supplement is given from the second day of life to 36 weeks' postmenstrual age (PMA). The primary outcome is brain maturation assessed by Magnetic Resonance Imaging (MRI) at term equivalent age. Secondary outcomes include quality of growth, incidence of neonatal morbidities, cardiovascular health and neuro-development. Target sample size is 120 infants (60 per group), this will provide 80% power to detect a 0.04 difference in mean diffusivity (MD, mm
DISCUSSION
Supplementation of ARA and DHA has the potential to improve brain maturation and reduce inflammation related diseases. This study is expected to provide valuable information for future nutritional guidelines for preterm infants.
TRIAL REGISTRATION
Clinicaltrials.gov ID: NCT03555019 . Registered 4 October 2018- Retrospectively registered.

Identifiants

pubmed: 33407269
doi: 10.1186/s12887-020-02425-x
pii: 10.1186/s12887-020-02425-x
pmc: PMC7789285
doi:

Substances chimiques

Docosahexaenoic Acids 25167-62-8
Arachidonic Acid 27YG812J1I

Banques de données

ClinicalTrials.gov
['NCT03555019']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19

Subventions

Organisme : Norges Forskningsråd
ID : 260552/h10

Investigateurs

Marlen Fossan Aas (MF)
Mona Kristiansen Beyer (MK)
Jens-Petter Berg (JP)
Marianne Bratlie (M)
Atle Bjornerud (A)
Maninder Singh Chawla (MS)
Siw Helen Westby Eger (SHW)
Cathrine Nygaard Espeland (CN)
Oliver Geier (O)
Gunnthorunn Gunnarsdottir (G)
Christina Henriksen (C)
Per Kristian Hol (PK)
Henrik Holmstrøm (H)
Ivan Maximov (I)
Tone Nordvik (T)
Madelaine Eloranta Rossholt (ME)
Helene Caroline Dale Osterholt (HCD)
Ingjerd Saeves (I)
Elin Blakstad (E)
Henriette Astrup (H)
Helge Froisland (H)
Lars Tveiten (L)
Krzysztof Hochnowski (K)
Terje Reidar Selberg (TR)
Henning Hoyte (H)
Randi Borghild Stornes (RB)
Hanne Isdal (H)
Thea Wauters Thyness (TW)
Petra Huppi (P)
Alexandre Lapillonne (A)

Références

J Pediatr Endocrinol Metab. 2012;25(3-4):317-21
pubmed: 22768663
Neonatal Netw. 2016;35(2):73-7
pubmed: 27052981
Arch Dis Child. 2014 Oct;99(10):887-91
pubmed: 24914095
Clin Nutr ESPEN. 2017 Aug;20:17-23
pubmed: 29072164
J Neuropathol Exp Neurol. 2012 Mar;71(3):251-64
pubmed: 22318128
Food Nutr Res. 2016 Nov 11;60:32162
pubmed: 27839532
Pediatrics. 2014 Jul;134(1):120-34
pubmed: 24913791
Neuroimage. 2019 Jan 15;185:813-824
pubmed: 29660514
Fetal Diagn Ther. 2018;43(2):113-122
pubmed: 28898865
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Acta Neuropathol. 2017 Sep;134(3):331-349
pubmed: 28534077
Semin Perinatol. 2009 Dec;33(6):364-71
pubmed: 19914520
Lancet. 2013 Mar 2;381(9868):774-5
pubmed: 23472921
Neonatology. 2015;107(1):68-75
pubmed: 25401387
J Perinatol. 2013 Nov;33(11):851-7
pubmed: 23765172
J Pediatr Gastroenterol Nutr. 2014 Mar;58(3):344-51
pubmed: 24556755
Nutr Clin Pract. 2009 Aug-Sep;24(4):487-99
pubmed: 19605803
Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F257-63
pubmed: 25425653
Arch Dis Child Fetal Neonatal Ed. 2008 Mar;93(2):F153-61
pubmed: 18296574
J Nutr. 2013 Dec;143(12 Suppl):2061S-2065S
pubmed: 24108136
Eur J Prev Cardiol. 2013 Apr;20(2):357-67
pubmed: 22345683
Chem Phys Lipids. 2003 Nov;126(1):1-27
pubmed: 14580707
Nutr Clin Pract. 2012 Dec;27(6):817-24
pubmed: 22878361
Nutrients. 2016 Apr 12;8(4):216
pubmed: 27077882
Mol Ther. 2018 Jul 5;26(7):1599-1609
pubmed: 29929790
Pediatrics. 2006 Aug;118(2):536-48
pubmed: 16882805
JPEN J Parenter Enteral Nutr. 2019 Sep;43(7):874-882
pubmed: 30614004
J Pediatr. 2009 Jan;154(1):39-43.e3
pubmed: 18760808
Childs Nerv Syst. 2019 Jun;35(6):917-927
pubmed: 30953157
AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2208-14
pubmed: 23620070
Pediatrics. 2001 Feb;107(2):270-3
pubmed: 11158457
J Pediatr Gastroenterol Nutr. 2005 Nov;41 Suppl 2:S1-87
pubmed: 16254497
Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):143-50
pubmed: 19577914
JAMA Pediatr. 2015 Mar;169(3):230-8
pubmed: 25621457
Early Hum Dev. 2014 Jan;90(1):27-31
pubmed: 24314586
Early Hum Dev. 2009 May;85(5):325-9
pubmed: 19217727
JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):711-6
pubmed: 23963690
J Pediatr. 2018 Jun;197:300-308
pubmed: 29551318
Clin Perinatol. 2015 Dec;42(4):797-806
pubmed: 26593079
Semin Fetal Neonatal Med. 2006 Oct;11(5):363-8
pubmed: 16581321
Reprod Health. 2013;10 Suppl 1:S2
pubmed: 24625129
Pediatr Int. 2012 Oct;54(5):715-7
pubmed: 23005906
Semin Perinatol. 2016 Jun;40(4):247-53
pubmed: 26804381
Pediatr Res. 2015 Nov;78(5):492-7
pubmed: 26186294
Am J Clin Nutr. 2007 May;85(5):1171-84
pubmed: 17490951
Semin Fetal Neonatal Med. 2018 Dec;23(6):400-405
pubmed: 30172660
Expert Opin Ther Targets. 2014 Mar;18(3):257-68
pubmed: 24392842
Early Hum Dev. 2016 Mar;94:25-30
pubmed: 26894665
Arch Dis Child. 2011 Mar;96(3):209-10
pubmed: 20852278
J Perinatol. 2015 Jan;35(1):1-7
pubmed: 25357095
AJNR Am J Neuroradiol. 2016 Jan;37(1):155-62
pubmed: 26494693
Pediatrics. 2011 Jul;128(1):e71-7
pubmed: 21708809
Am J Physiol Gastrointest Liver Physiol. 2005 Oct;289(4):G643-52
pubmed: 15947118
J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):85-91
pubmed: 19881390
Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F501-4
pubmed: 14602698
Am J Obstet Gynecol. 2014 Jun;210(6):550.e1-7
pubmed: 24440565
JPEN J Parenter Enteral Nutr. 2020 May 26;:
pubmed: 32458478
N Engl J Med. 2017 Mar 30;376(13):1245-1255
pubmed: 28355511
Eur J Nutr. 2016 Oct;55(7):2265-74
pubmed: 26363610
Neuroimage. 2019 Jan 15;185:699-710
pubmed: 29913282
PLoS One. 2013 Aug 15;8(8):e72880
pubmed: 23977367
J Pediatr. 2011 Nov;159(5):743-749.e1-2
pubmed: 21658712
Nutr Rev. 1992 Apr;50(4 ( Pt 2)):38-45
pubmed: 1608564
Diabetologia. 1993 Jan;36(1):62-7
pubmed: 8436255
Pediatr Res. 2017 May;81(5):787-794
pubmed: 28141791
Nat Rev Immunol. 2008 May;8(5):349-61
pubmed: 18437155
PLoS One. 2013 May 29;8(5):e64325
pubmed: 23734194
Cereb Cortex. 2012 Nov;22(11):2478-85
pubmed: 22109543
J Pediatr. 2010 Nov;157(5):745-50.e1
pubmed: 20598319
J Perinatol. 2010 Sep;30(9):610-5
pubmed: 20182437
Am J Physiol Lung Cell Mol Physiol. 2011 Dec;301(6):L860-71
pubmed: 21873446
Clin Nutr. 2018 Dec;37(6 Pt B):2303-2305
pubmed: 30471662
Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R306-13
pubmed: 17428893
Placenta. 2005 Apr;26 Suppl A:S70-5
pubmed: 15837071
JAMA. 2019 Mar 26;321(12):1188-1199
pubmed: 30912837
Clin Nutr. 2018 Dec;37(6 Pt B):2344-2353
pubmed: 30064846
Pediatrics. 2008 Oct;122(4):743-51
pubmed: 18829797
Lancet Infect Dis. 2014 Aug;14(8):751-762
pubmed: 24877996
World Rev Nutr Diet. 2014;110:82-98
pubmed: 24751623
J Pediatr. 2013 Mar;162(3 Suppl):S37-47
pubmed: 23445847
N C Med J. 2017 Mar-Apr;78(2):124-128
pubmed: 28420777
J Neonatal Perinatal Med. 2016 Sep 16;9(3):233-42
pubmed: 27589549
Am J Clin Nutr. 2007 Feb;85(2):614S-620S
pubmed: 17284765
Clin Nutr. 2013 Apr;32(2):207-12
pubmed: 23043722
N Engl J Med. 2008 Jul 17;359(3):262-73
pubmed: 18635431

Auteurs

Kristina Wendel (K)

Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway. krwend@ous-hf.no.

Helle Cecilie Viekilde Pfeiffer (HCV)

Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway.
Department of Pediatric Neurology, Oslo University Hospital, Oslo, Norway.

Drude Merete Fugelseth (DM)

Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Eirik Nestaas (E)

Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway.
Department of Pediatrics, Vestfold Hospital Trust, Tønsberg, Norway.

Magnus Domellöf (M)

Department of Clinical Sciences, Pediatrics, Umea University, Umea, Sweden.

Bjorn Steen Skålhegg (BS)

Division of Molecular Nutrition, Department of Nutrition, University of Oslo, Oslo, Norway.

Katja Benedikte Presto Elgstøen (KBP)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.

Helge Rootwelt (H)

Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.

Rolf Dagfinn Pettersen (RD)

Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.

Are Hugo Pripp (AH)

Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.

Tom Stiris (T)

Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Sissel J Moltu (SJ)

Department of Neonatal Intensive Care, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH